EVENTS

ZeClinics will participate in the ESTIV 2022 congress

21st International Congress of the European Society of Toxicology In Vitro

EVENTS

Come talk to the ZeClinics crew at BIO Japan2022!

BioJapan Oct 12-14, PACIFICO Yokohama

EVENTS

We are presenting at ICT 2022

XVIth International Congress of Toxicology

ZECLINICS NEWS

EUROSTARS CARDIOMYO consortium has launched a HTS platform to identify new therapies for cardiomyopathies

zebrafish ZECLINICS NEWS

Zebrafish can repair the heart after suffering a heart attack

MEDIA

Combining AI and Zebrafish to Accelerate Drug Discovery

As part of our SLAS Europe 2022 coverage, we speak to Dr. Javier Terriente, Co-founder and CDD at ZeClinics, about how zebrafish could be the future for discovering new therapeutics.

EVENTS

ZeClinics is speaking at JSOT 2022!

49th Annual Meeting of the Japanese Society of Toxicology

MEDIA

BIO 2022: 20 European innovators paved the way for innovation and strategic business partnerships overseas

Over the course of the four-day tradeshow, the European presence was prevalent during the high-level sessions.

EVENTS

ZeClinics is partnering in the BIO International Convention 2022

San Diego, California. European Pavilion, Booth 1911.

EVENTS

We are speaking at SLAS Europe 2022!

Society for Laboratory Automation and Screening Europe 2022 Conference & Exhibition, Dublin.

ZECLINICS NEWS

ZeClinics partners with the Institut de la Vision to test in zebrafish the most cutting-edge genome editing technologies

MEDIA

ZeClinics se asocia con el Institut de la Vision de París para testar en peces cebra las tecnologías de edición genómica más punteras

ZeClinics ha iniciado una colaboración con el investigador Filippo del Bene para desarrollar enfoques innovadores que permitan realizar modificaciones genéticas complejas

MEDIA

Un caso de estudio perfecto de la alianza exitosa entre CRO y Pharma

ZeClinics y Dompé Farmaceutici iniciaron esta colaboración hace unos años, en un esfuerzo por validar el uso del pez cebra para modelar de forma fiable las retinopatías humanas

Reducing-data-heterogeneity-with-ontologies. ZECLINICS NEWS

New article publication by ZeClinics and the SEAZIT program from the National Institute of Health

new-article-publication-by-ZeClinics-and-Dompé ZECLINICS NEWS

New article publication by ZeClinics and Dompé Farmaceutici

ZECLINICS NEWS

ZeClinics reached hire 20% of its workforce in 2021